USDM Life Sciences Chosen by FDA to Assess Pharmaceutical Readiness for Drug Supply Chain Security Act

Share Article

USDM Life Sciences was selected by FDA to develop and implement a program for the Drug Supply Chain Security Act (DSCSA) pilot projects.

News Image
We are ready to add to FDA’s overall goal to improve patient safety.

USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce it was selected by FDA to develop and implement a program for the Drug Supply Chain Security Act (DSCSA) pilot projects.

“We are pleased to be working with FDA on this critical initiative for the life science and healthcare industries,” said James Macdonell, Vice President of Services and Solutions at USDM Life Sciences. “We are ready to add to FDA’s overall goal to improve patient safety.”

For FDA’s “Pilot Projects for Drug Supply Chain Security Act,” USDM Life Sciences and its strategic business partners including RC Partners and The Clarion Group will execute this engagement.

About USDM Life Sciences:
USDM Life Sciences has more than 15 years of experience supplying clients in the life science and healthcare industries with compliance services while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries.

About RC Partners:
RC Partners,Inc. monitors, interprets and clarifies healthcare industry trends, including legislative and regulatory changes and forecasts. They carefully study the implications of these developments to assist clients in interpreting them for their individual needs. Their healthcare consultancy, simulation modeling and educational modules focus primarily on clarification of and navigation through the Drug Supply Chain Security Act (DSCSA) and Unique Device Identification (UDI). RC Partners has developed a patent-pending VirtualPilotTM service that allows pilot teams to accelerate the process of learning, discovery and decision-making.

About The Clarion Group, Inc.
The Clarion Group, Inc. is an event management firm specializing in the production of technology conferences and events. With extensive experience in producing all aspects of events – from concept to on-site execution – they help their clients to create successful events to enhance their influence and forward their initiatives. The Clarion Group’s goal is to improve their clients’ educational outreach through high quality event production.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ryan Carmel
USDM Life Sciences
+1 805-856-2660
Email >
Visit website